{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T13:03:26Z","timestamp":1784898206921,"version":"3.55.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologie"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00120-026-02876-7","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:22:17Z","timestamp":1782926537000},"page":"883-890","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antibiotic Stewardship in der Urologie","Antibiotic stewardship in urology"],"prefix":"10.1007","volume":"65","author":[{"given":"Fabian P.","family":"Stangl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Magistro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"2876_CR1","doi-asserted-by":"publisher","unstructured":"Murray C, Ikuta K, Sharara F et\u00a0al (2022) Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399(10325):629\u2013655. https:\/\/doi.org\/10.1016\/s0140-6736(21)02724-0","DOI":"10.1016\/s0140-6736(21)02724-0"},{"key":"2876_CR2","unstructured":"O\u2019Neill J (2016) Tackling drug-resistant infections globally: final report and recommendations. Zugegriffen: 2018"},{"key":"2876_CR3","unstructured":"Bonkat G, Bartoletti R, Bruy\u00e8re F et\u00a0al (2025) EAU Guidelines on Urological Infections. https:\/\/d56bochluxqnz.cloudfront.net\/documents\/full-guideline\/EAU-Guidelines-on-Urological-infections-2025.pdf"},{"key":"2876_CR4","unstructured":"DGfUeV (Hrsg) (2024) S3 Leitlinie: Epidemiologie, Diagnostik, Therapie, Pr\u00e4vention und Management unkomplizierter, bakterieller, ambulant erworbener Harnwegsinfektionen bei Erwachsenen - Aktualisierung 2024. Langversion 3.0, AWMF Registernummer: 043\/044."},{"issue":"11","key":"2876_CR5","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s00120-022-01898-1","volume":"61","author":"L Schneidewind","year":"2022","unstructured":"Schneidewind\u00a0L, Stangl\u00a0FP, Dr\u00e4ger\u00a0DL, Wagenlehner\u00a0FME, Hakenberg\u00a0OW, Kranz\u00a0J (2022) What is the proportion of infectiology in the specialization urology? : A pilot study to underline the significance of Antibiotic Stewardship in urology. Urologie 61(11):1237\u20131242. https:\/\/doi.org\/10.1007\/s00120-022-01898-1","journal-title":"Urologie"},{"issue":"2","key":"2876_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00120-024-02469-2","volume":"64","author":"WV Kern","year":"2025","unstructured":"Kern\u00a0WV, Baumann\u00a0J, F\u00f6rst\u00a0G et\u00a0al (2025) [Antibiotic prescribing practice in urological departments in Germany: results of a cross-sectional study]. Urologie. Feb 2025;64(2):165\u2013172. Antibiotikaverschreibung in urologischen Kliniken Deutschlands: Ergebnisse einer Querschnittstudie. Urologie 64(2):165\u2013172. https:\/\/doi.org\/10.1007\/s00120-024-02469-2","journal-title":"Urologie"},{"issue":"1","key":"2876_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanmic.2024.07.010","volume":"6","author":"CS Ho","year":"2025","unstructured":"Ho\u00a0CS, Wong\u00a0CTH, Aung\u00a0TT et\u00a0al (2025) Antimicrobial resistance: a concise update. Lancet Microbe 6(1):100947. https:\/\/doi.org\/10.1016\/j.lanmic.2024.07.010","journal-title":"Lancet Microbe"},{"key":"2876_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2025.07.005","author":"FP Stangl","year":"2025","unstructured":"Stangl\u00a0FP, Day\u00a0E, Vall\u00e9e\u00a0M et\u00a0al (2025) Infectious Complications After Transrectal Versus Transperineal Prostate Biopsy: A Systematic Review and Meta-analysis. Eur Urol Oncol. https:\/\/doi.org\/10.1016\/j.euf.2025.07.005","journal-title":"Eur Urol Focus"},{"issue":"2","key":"2876_CR9","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/ju.0000000000000814","volume":"204","author":"A Pilatz","year":"2020","unstructured":"Pilatz\u00a0A, Dimitropoulos\u00a0K, Veeratterapillay\u00a0R et\u00a0al (2020) Antibiotic Prophylaxis for the Prevention of Infectious Complications following Prostate Biopsy: A Systematic Review and Meta-Analysis. J\u00a0Urol 204(2):224\u2013230. https:\/\/doi.org\/10.1097\/ju.0000000000000814","journal-title":"J Urol"},{"key":"2876_CR10","doi-asserted-by":"crossref","unstructured":"Draenert\u00a0R, Weber\u00a0A, Jung\u00a0J, Arenz\u00a0L (2025) Perioperative antibiotic prophylaxis-The new German S3 guideline. Die Anaesthesiologie.","DOI":"10.1007\/s00101-025-01567-w"},{"issue":"9995","key":"2876_CR11","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/s0140-6736(15)61522-7","volume":"386","author":"NICE","year":"2015","unstructured":"NICE (2015) antimicrobial stewardship: right drug, dose, and time? Lancet 386(9995):717\u2013717. https:\/\/doi.org\/10.1016\/s0140-6736(15)61522-7","journal-title":"Lancet"},{"issue":"1","key":"2876_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/QCO.0000000000000228","volume":"29","author":"Z Tandogdu","year":"2016","unstructured":"Tandogdu\u00a0Z, Wagenlehner\u00a0FM (2016) Global epidemiology of urinary tract infections. Curr Opin Infect Dis 29(1):73\u201379. https:\/\/doi.org\/10.1097\/QCO.0000000000000228","journal-title":"Curr Opin Infect Dis"},{"issue":"11","key":"2876_CR13","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1093\/cid\/civ696","volume":"61","author":"T Cai","year":"2015","unstructured":"Cai\u00a0T, Nesi\u00a0G, Mazzoli\u00a0S et\u00a0al (2015) Asymptomatic bacteriuria treatment is associated with a higher prevalence of antibiotic resistant strains in women with urinary tract infections. Clinical Infectious Diseases 61(11):1655\u20131661","journal-title":"Clinical Infectious Diseases"},{"key":"2876_CR14","doi-asserted-by":"crossref","unstructured":"Burgos\u00a0JG, Jirsova\u00a0E, Kranz\u00a0J, Bonkat\u00a0G (2025) A\u00a0call to prevent inappropriate prescribing of fluoroquinolones from the European medicines agency and the European association of urology guidelines panel for urological infections. p. S0302\u20132838.","DOI":"10.1016\/j.eururo.2025.07.015"},{"issue":"2","key":"2876_CR15","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1001\/jama.2018.19283","volume":"321","author":"ES Shenoy","year":"2019","unstructured":"Shenoy\u00a0ES, Macy\u00a0E, Rowe\u00a0T, Blumenthal\u00a0KG (2019) Evaluation and management of penicillin allergy: a review. Jama 321(2):188\u2013199","journal-title":"Jama"},{"issue":"12","key":"2876_CR16","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.cmi.2022.06.017","volume":"28","author":"Y Kau\u00dfner","year":"2022","unstructured":"Kau\u00dfner\u00a0Y, R\u00f6ver\u00a0C, Heinz\u00a0J et\u00a0al (2022) Reducing antibiotic use in uncomplicated urinary tract infections in adult women: a\u00a0systematic review and individual participant data meta-analysis. Clinical Microbiology and Infection 28(12):1558\u20131566","journal-title":"Clinical Microbiology and Infection"},{"issue":"10","key":"2876_CR17","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/s1473-3099(22)00373-5","volume":"22","author":"M Jacewicz","year":"2022","unstructured":"Jacewicz\u00a0M, G\u00fcnzel\u00a0K, Rud\u00a0E et\u00a0al (2022) Antibiotic prophylaxis versus no antibiotic prophylaxis in transperineal prostate biopsies (NORAPP): a randomised, open-label, non-inferiority trial. Lancet Infect Dis 22(10):1465\u20131471. https:\/\/doi.org\/10.1016\/s1473-3099(22)00373-5","journal-title":"Lancet Infect Dis"},{"key":"2876_CR18","doi-asserted-by":"crossref","unstructured":"Wolff I, B\u00fcchner M, Hauner K, et\u00a0al (2024) Infectious complications following transperineal prostate biopsy with or without periprocedural antibiotic prophylaxis\u2014a systematic review including meta-analysis of all comparative studies. Prostate Cancer and Prostatic Diseases:1\u201310.","DOI":"10.1038\/s41391-024-00934-9"},{"key":"2876_CR19","doi-asserted-by":"publisher","unstructured":"Sommerstein R, Troillet N, Harbarth S, et\u00a0al (2023) Timing of Cefuroxime Surgical Antimicrobial Prophylaxis and Its Association With Surgical Site Infections. JAMA Netw Open. Jun 1 6(6):e2317370. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.17370","DOI":"10.1001\/jamanetworkopen.2023.17370"}],"container-title":["Die Urologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-026-02876-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00120-026-02876-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-026-02876-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T12:19:37Z","timestamp":1784895577000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00120-026-02876-7"}},"subtitle":["Zeit umzudenken?","Time to rethink?"],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2876"],"URL":"https:\/\/doi.org\/10.1007\/s00120-026-02876-7","relation":{},"ISSN":["2731-7064","2731-7072"],"issn-type":[{"value":"2731-7064","type":"print"},{"value":"2731-7072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"27 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autorinnen und Autoren sowie die Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":1,"name":"Ethics","label":"Interessenkonflikt","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"G. Magistro\n                      : A. Finanzielle Interessen: Bionorica SE \u2013\u00a0Advisory Board, Repha Pharma GmbH\u00a0\u2013 Vortrag. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Chefarzt\u00a0\u2013 Klinik f\u00fcr Urologie am Asklepios Westklinikum Hamburg | Vorsitz Arbeitskreis Infektiologie und Hygiene der Deutschen Gesellschaft f\u00fcr Urologie (DGU), Mitglied Arbeitskreis Benignes Prostatasyndrom der DGU.\n                      F.\u00a0Stangl\n                      : A.\u00a0Finanzielle Interessen: Vortragshonorare oder Kostenerstattung als passiv Teilnehmende: Accord, Janssen, Bayer, OM Pharma. \u2013\u00a0Bezahlte Beratungsleistungen, interne Schulungsvortr\u00e4ge, Gehaltsbezug o.\u202f\u00e4.: Accord, OM Pharma.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Gesch\u00e4ftsf\u00fchrender Oberarzt an der Klinik und Poliklinik f\u00fcr Urologie und Kinderurologie des Universit\u00e4tsklinikums W\u00fcrzburg | EAU- und S3-Leitlinien.","order":2,"name":"Ethics","label":"Autorinnen und Autoren","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf\n                      \n                      .","order":3,"name":"Ethics","label":"Wissenschaftliche Leitung","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":4,"name":"Ethics","label":"Der Verlag","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}}]}}